- US-based biotechnology company Dyne Therapeutics is supporting END-DM1, a natural history study to advance the understanding of disease progression in patients with myotonic
dystrophy type 1 and enable the development of clinical outcome assessments, the company said.
They restored muscle stem cell function that is impaired in Duchenne muscular
dystrophy, resulting in efficient regeneration of the muscle and preventing the progressive loss of muscle strength characteristic of the disease.
Muscular
Dystrophy UK's chief executive Catherine Woodhead, said: "Mia has shown remarkable maturity in giving up her time to take on both exhilarating activities and tireless fundraising and she has shown a selfless 'go and do' attitude to make a difference for her brother and others with a muscle wasting condition."
Among the SCDs, Granular corneal
dystrophy and Macular corneal
dystrophy are more frequent as compared to other stromal dystrophies.1 A retrospective analysis was performed between November 2014 and July 2015 on all SCD patients visiting LRBT, General Hospital and Mughal Eye Hospital from Lahore during their ophthalmic consultation.
Bo Wu, Ph.D., from the McColl-Lockwood Laboratory for Muscular
Dystrophy Research in Charlotte, N.C., and colleagues examined the therapeutic values of tamoxifen and raloxifene in FKRPP448L mutant mice with severe dystrophic phenotype.
There was histological examination after death with the following observations: muscle
dystrophy and atrophy in all skeletal muscles including diaphragm, representing different size of myocytes, fibrous tissues among the cells, and diffuse lipomatosis.
It enrolled 25 boys and young men in advanced stages of Duchenne muscular
dystrophy and was conducted at three U.S.
Primary choroidal dystrophies which affect the central macula are referred to as central areolar choroidal
dystrophy, posterior polar central choroidal
dystrophy, posterior polar annular
dystrophy, posterior polar hemispheric
dystrophy, and central and peripheral annular choroidal
dystrophy.
M2 EQUITYBITES-July 28, 2017-AMO Pharma wins US FDA's orphan drug designation for AMO-02 for treatment of congenital myotonic
dystrophyOur aim was to observe the facial morphology and certain features of oro-facial function in patients with different forms of muscle
dystrophy. This study was conducted in the Division of Morbid Anatomy and Histopathology at University of Health Sciences after ethical review committee approval.
ABERDARE Park was turned orange on Sunday for a charity walk raising funds and awareness for Muscular
Dystrophy UK.
Global Markets Direct's, 'Muscular
Dystrophy - Pipeline Review, H1 2016', provides an overview of the Muscular
Dystrophy pipeline landscape.
Murphy wants to raise the awareness of Muscular
Dystrophy throughout Connecticut.
